We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
-2.06%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$614M
AUM Growth
-$35.7M
Cap. Flow
-$16.7M
Cap. Flow %
-2.73%
Top 10 Hldgs %
8.77%
Holding
722
New
115
Increased
83
Reduced
345
Closed
120

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$3.16M
2
AMD icon
Advanced Micro Devices
AMD
+$2.25M
3
VEEV icon
Veeva Systems
VEEV
+$2.23M
4
FANG icon
Diamondback Energy
FANG
+$2.21M
5
PCG icon
PG&E
PCG
+$2.18M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$2.94M
2
GD icon
General Dynamics
GD
+$2.93M
3
PSX icon
Phillips 66
PSX
+$2.76M
4
ALGN icon
Align Technology
ALGN
+$2.65M
5
LHX icon
L3Harris
LHX
+$2.56M

Sector Composition

Rank Sector Weight
1 Financials 18.75%
2 Technology 17.73%
3 Healthcare 12.62%
4 Industrials 11.81%
5 Consumer Discretionary 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVB icon
551
Nuvation Bio
NUVB
$2.32B
$162K 0.03%
55,509
-62,548
-53% -$191K
GBIO
552
DELISTED
Generation Bio
GBIO
$162K 0.03%
5,742
-1,675
-23% -$54.4K
GLUE icon
553
Monte Rosa Therapeutics
GLUE
$1.35B
$157K 0.03%
41,917
-476
-1% -$2.43K
ORIC icon
554
Oric Pharmaceuticals
ORIC
$1.4B
$154K 0.03%
+21,738
New +$195K
RLAY icon
555
Relay Therapeutics
RLAY
$4.33B
$149K 0.02%
22,854
-234
-1% -$1.6K
PRME icon
556
Prime Medicine
PRME
$559M
$149K 0.02%
28,923
-318
-1% -$1.93K
ALLO icon
557
Allogene Therapeutics
ALLO
$694M
$148K 0.02%
63,470
-633
-1% -$1.87K
FHTX icon
558
Foghorn Therapeutics
FHTX
$360M
$147K 0.02%
25,567
-252
-1% -$1.5K
RCM
559
DELISTED
R1 RCM Inc. Common Stock
RCM
$146K 0.02%
11,615
-104,509
-90% -$1.3M
FATE icon
560
Fate Therapeutics
FATE
$326M
$143K 0.02%
43,472
-340
-0.8% -$1.49K
RGNX icon
561
Regenxbio
RGNX
$708M
$142K 0.02%
12,168
-88
-0.7% -$1.37K
LYEL icon
562
Lyell Immunopharma
LYEL
$360M
$140K 0.02%
4,814
-42
-0.9% -$2K
ERAS icon
563
Erasca
ERAS
$6.39B
$136K 0.02%
57,504
-541
-0.9% -$1.17K
TCRX icon
564
TScan Therapeutics
TCRX
$52M
$134K 0.02%
+22,940
New +$181K
MGTX icon
565
MeiraGTx Holdings
MGTX
$1.21B
$134K 0.02%
31,716
-246
-0.8% -$1.24K
IPSC icon
566
Century Therapeutics
IPSC
$361M
$130K 0.02%
51,015
-505
-1% -$1.6K
CCCC icon
567
C4 Therapeutics
CCCC
$412M
$125K 0.02%
+27,136
New +$162K
SAGE
568
DELISTED
Sage Therapeutics
SAGE
$119K 0.02%
10,935
-113
-1% -$1.45K
ALEC icon
569
Alector
ALEC
$199M
$110K 0.02%
24,319
-213
-0.9% -$1.1K
STRO icon
570
Sutro Biopharma
STRO
$421M
$104K 0.02%
3,536
-33
-0.9% -$1.3K
CTMX icon
571
CytomX Therapeutics
CTMX
$754M
$98.3K 0.02%
80,591
-761
-0.9% -$1.51K
EDIT icon
572
Editas Medicine
EDIT
$442M
$93K 0.02%
19,906
-254
-1% -$1.43K
IVVD icon
573
Invivyd
IVVD
$218M
$85.5K 0.01%
+77,753
New +$172K
BCAB icon
574
BioAtla
BCAB
$5.74M
$83K 0.01%
1,212
-12
-1% -$1.43K
VSTM icon
575
Verastem
VSTM
$610M
$74.7K 0.01%
25,064
-210
-0.8% -$1.73K
21 22
23
24 25

Similar funds

NWM
NRI Wealth Management Santa Clara, California $196M AUM 32.41% 1-Year Est. Return
MAM
McCarthy Asset Management Redwood Shores, California $192M AUM 10.3% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund X Houston, Texas $216M AUM 11.92% 1-Year Est. Return
PSB
Passumpsic Savings Bank St. Johnsbury, Vermont $183M AUM
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
NMG
New Millennium Group Sandy, Utah $231M AUM 33.06% 1-Year Est. Return
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
BC
Bowman & Company Oshkosh, Wisconsin $237M AUM 16.16% 1-Year Est. Return

Cornercap Investment Counsel's Q2 2024 Portfolio in Review

As of Q2 2024, Cornercap Investment Counsel held 722 positions worth $614M, down 5.5% from $649M the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Cornercap Investment Counsel's Q2 2024 filing shows 115 new, 83 increased, 345 reduced and 120 closed positions. Its largest new stake was Comcast: 80,638 shares worth $3.16M. The largest sale was Palo Alto Networks, an estimated $2.94M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.

  • Cornercap Investment Counsel's largest Q2 2024 buy was Comcast: 80,638 shares worth $3.16M.
  • Cornercap Investment Counsel added most to Advanced Micro Devices in Q2 2024, an estimated $2.25M increase.
  • Cornercap Investment Counsel's biggest Q2 2024 reduction was Palo Alto Networks, cutting an estimated $2.94M.
  • Cornercap Investment Counsel fully exited General Dynamics in Q2 2024, selling an estimated $2.93M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.8% of its $614M portfolio in Q2 2024.
  • Cornercap Investment Counsel opened 115 new positions and closed 120 in Q2 2024.
  • Cornercap Investment Counsel's portfolio value fell 5.5% quarter-over-quarter to $614M.

Based on Cornercap Investment Counsel's 13F filing for Q2 2024, filed 8 Aug 2024.